News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC – Debyani Chakravarty
Photo taken from: Debyani Chakravarty / Twitter
Jul 17, 2023, 09:59

Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC – Debyani Chakravarty

My OncoKB people: Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC.

Looking fwd to it getting tumor agnostic approval based on Alison Schram work showing 42% ORR in PDAC (& 35% in NSCLC).

 

Source: Debyani Chakravarty / Twitter

FDA OncoDaily Oncology zenocutuzumab
Special Coverage
Blog
Dec 22, 2024, 05:28
Luis E Raez: Annual GO2 Foundation for Lung Cancer Walk/Run to raise funds and awareness
Blog
Dec 22, 2024, 05:25
Punita Khanna: Advances in breast cancer research, testing, treatment and therapies at the SABCS2024
Insight
Dec 22, 2024, 05:22
Camilla Perucchini: I have officially graduated with a Master of Science in Biotechnology curriculum
Career
Dec 22, 2024, 05:19
Sidra Naz has been honored with the 2025 Early Career Investigator Award in Healthcare Disparities Research in IBD
Blog
Dec 22, 2024, 05:17
Rasha Aboelhassan: Oncologists are overwhelmed by their own fights against cancer
Blog
Dec 22, 2024, 05:15
Jemma Arakelyan: Collaboration plans between City University of Hong Kong and Shenzhen Hospital of Southern Medical University
Blog
Dec 22, 2024, 05:13
The Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute